Top View
- Studies of Salvinorin-Based Antagonists to Elucidate Pertinent Interactions for Kappa Opioid Receptor Antagonism
- 4Th Meeting Program and Abstract Book
- Poster Session I As Demonstrated by Reduced Levels of KOR Mrna and KOR Binding, to Follow up Initial Findings That Systemic Blockade of M2
- Investigação Da Participação De Adrenoceptores Α1a E
- Program Book Cover2
- Selective K Opioid Antagonists Nor-BNI, GNTI and Jdtic Have Low Affinities for Non-Opioid Receptors and Transporters
- HHS Public Access Author Manuscript
- Studies Toward Bivalent Κ Opioids Derived from Salvinorin A: Heteromethylation of the Furan Ring Reduces Affinity
- Long-Acting Opioid Antagonists Nor-BNI, GNTI And
- Synthesis and Biological Evaluation of Dynorphin Analogs, and Caco-2 Permeability of Opioid Macrocyclic Tetrapeptides
- Opioids and Sickle Cell Disease: from Opium to the Opioid Epidemic
- Kappa Antagonist Jdtic in Phase 1 Clinical Trial
- Chemogenomics Knowledgebase and Systems Pharmacology for Hallucinogen Target Identification Salvinorin a As a Case Study
- Structure of the Human Κ-Opioid Receptor in Complex with Jdtic
- Bioactive Compound Library Plus (96-Well)
- A Single Compound Alternative to a Buprenorphine/Naltrexone Combination Irna Elina Ridzwan a Thesis Submitted for the Degree Of
- En Busca Del Opioide Ideal. Nuevas Moléculas
- 阿片受体激动剂研究进展advances in Research on Opioid Receptor
- Studies Toward Bivalent Κ Opioids Derived from Salvinorin A: Heteromethylation of the Furan Ring Reduces Affinity
- Development of Pharmacotherapies for Drug Addiction: a Rosetta Stone Approach
- University of California
- Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain
- Molecular Pharmacology of Δ-Opioid Receptors
- NDSP Catalog 23Rd Edition
- I. Development of Bisamides As Kappa Opioid Receptor Agonists. II
- Salvinorin A, a Kappa-Opioid Receptor Agonist Hallucinogen: Pharmacology and Potential Template for Novel Pharmacotherapeutic Agents in Neuropsychiatric Disorders
- (12) United States Patent (10) Patent No.: US 7,678,808 B2 Barlow Et Al
- 1 the Κ-Opioid Receptor Antagonist Jdtic Decreases Ethanol Intake In
- Opioid Receptor
- Joseph H. Porter · Adam J. Prus Editors the Behavioral Neuroscience of Drug Discrimination Current Topics in Behavioral Neurosciences
- A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of Jdtic
- Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
- Jdtic | Medchemexpress
- Bifunctional Opioid Peptidomimetics: Studies on Affinity and Efficacy By
- Opioid Receptor Antagonist Jdtic Attenuates the Alcohol Deprivation Effect in Rats 1387
- The Neurobiology and Pharmacology of Addiction
- PRESTO-Tango As an Open-Source Resource for Interrogation of the Druggable Human Gpcrome
- (12) United States Patent (10) Patent No.: US 7,998,971 B2 Barlow Et Al
- In Vitro and in Vivo Profile of Ppl-101 and Ppl-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential
- Effect of the Selective Kappa-Opioid Receptor Antagonist Jdtic on Nicotine Antinociception, Reward, and Withdrawal in the Mouse
- Ligand-Directed C-Jun N-Terminal Kinase Activation Disrupts Opioid Receptor Signaling
- Opiate Addiction and Cocaine Addiction: Underlying Molecular Neurobiology and Genetics
- Pharmacological Assessment of Adjuncts to Enhance Mu-Opioid Receptor Agonist Antinociception in Male Rhesus Monkeys: Does One + One = Three?
- Modifications to the Synthesis of the Salvinorin a Carbon Skeleton
- BU08073 a Buprenorphine Analog with Partial Agonist Activity at Mu Receptors in Vitro but Long
- Discrepancies in Kappa Opioid Agonist Binding Revealed Through PET Imaging † † ‡ † † Michael S
- Marijuana, Methamphetamine, and Oxycodone: a Multilevel Approach to Understanding Drug Effects